Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Pathway Therapeutics

Pathway Therapeutics

Pathway Therapeutics develops inhibitors of PI3-kinase for the treatment of cancer and inflammatory diseases.

OverviewStructured DataIssuesContributorsActivity
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Pathway Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo